-
Although there are few studies that specifically look at the elderly, this review provides useful information on the diagnosis and treatment of acute exacerbation of COPD and chronic bronchitis.
-
In women, insomnia was not associated with increased risk of death, regardless of sleep duration. In men, mortality risk was significantly increased only in insomniacs who slept less than 6 hours and who were diabetic or hypertensive at baseline.
-
-
In this issue: FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
Although corticosteroids are beneficial in treating severe exacerbations of chronic obstructive pulmonary disease (COPD), studies to date have not shown high-doses (such as methylprednisolone, 2 mg/kg or more per 24 h) administered intravenously (IV) to be superior to lower doses (e.g., prednisone, 40 mg/day) given orally, with respect to clinically important outcomes.
-
Paralytic agents such as vecuronium and cis-atracurium have been used as "rescue therapies" in patients with ARDS for many years, but, as with other rescue strategies including prone mechanical ventilation or inhaled vasodilators, evidence of a mortality benefit from this intervention has been lacking.
-
-
Project IMPACT, a proprietary database originally created by the Society for Critical Care Medicine and now maintained by Cerner Corp., collects data from a voluntary consortium of ICUs across America.
-
When complaints of dizziness in elderly patients were evaluated in primary care offices, the most common cause was cardiovascular disease, combined with contributions from adverse drug reactions. This contradicts many previous studies done in tertiary care settings where vertigo or vestibular disease was found to be the most common cause.
-